News of Note—Lonza adds API lines for AstraZeneca; Biocon gets EU OK

stock market prices
(Pixabay)

> Lonza is adding two lines at its site in Visp, Switzerland, for production of highly potent APIs as part of a supply deal with AstraZeneca. Release

> Indian biosimilar maker Biocon says its biologics drug product facility and its drug substance facility in Bengaluru were approved by the European Medicines Agency following a March inspection. Release

> AptarGroup in Crystal Lake, Illinois, is spending about $50 million to buy pharmaceutical services companies Nanopharm and Gateway Analytical to expand its offerings to the biopharma industry. Release

> The Medicines and Healthcare products Regulatory Agency in the U.K. is recalling two batches of 500 mg paracetamol tablets produced by M&A Pharmachem because of discoloration caused by fungi. Stor

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.